ORI Updates

ORI has released two notice of funding opportunity announcements (NOFOs) for projects, conferences, and workshops that advance the evolving field of research integrity and produce tangible outcomes related to ensuring the integrity and reliability of Public Health Service (PHS) funded research. 

ORI's Extramural Research Program awarded three Research on Research Integrity Conferences grants, two Research Integrity Program Development and Evaluation grants, and one Considerations, Options, and Resources for Data Management in PHS Funded Research cooperative agreement.

ORI continues to seek non-federal public and private sector entities to co-sponsor ORI conferences or workshops. Potential co-sponsors must have a demonstrated interest in and experience with research integrity, the responsible conduct of research (RCR), or the handling of research misconduct allegations. A conference for senior research officials and RIO boot camps are anticipated for 2022.

ORI found that Ya Wang, M.D., Ph.D., retired Professor and Director, Division of Experimental Radiation Oncology, Department of Radiation Oncology, Winship Cancer Institute, EU, engaged in research misconduct in research supported by U.S. Public Health Service (PHS) funds, specifically National Cancer Institute (NCI), National Institutes of Health (NIH), and National Institute of General Medical Sciences (NIGMS), NIH.

ORI found that Viravuth Yin, Ph.D., former Associate Professor, MDIBL, engaged in research misconduct in research supported by U.S. Public Health Service (PHS) funds, specifically National Institute of General Medical Sciences (NIGMS), National Institutes of Health (NIH).

ORI has released two FY 2022 grant opportunity forecasts for projects, conferences, and workshops that advance the evolving field of research integrity and produce tangible outcomes related to ensuring research integrity and compliance with 42 C.F.R. Part 93.

ORI will be hiring a Health Scientist at the GS 13 level. The Health Scientist will manage all activities related to assigned cases of alleged research misconduct in biomedical research studies, apply their technical knowledge and scientific expertise to develop overall plans to evaluate institutional research misconduct investigations, and evaluate evidence and prepare cases to support findings of research misconduct and recommend administrative actions.

Elisabeth (Lis) Handley, previously the Director of ORI, has accepted a new role as the Principal Deputy Assistant Secretary for Health (PDASH) in the Office of the Assistant Secretary for Health (OASH). Dr. Wanda Jones will remain Acting Director for ORI. 

To assist institutions with determining whether a significant issue or lead may be relevant while conducting a research misconduct proceeding, ORI has constructed several hypothetical case examples and included them in an informational document.

Recordings and slide decks from the May 6, 2021 and May 10, 2021 Notice of Funding Opportunity Technical Assistance Webinars are now available.